Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/73041
Full metadata record
DC FieldValueLanguage
dc.creatorAna Margarida da Cruz Alves
dc.date.accessioned2025-11-09T04:36:52Z-
dc.date.available2025-11-09T04:36:52Z-
dc.date.issued2014-05-27
dc.date.submitted2014-03-20
dc.identifier.othersigarra:29213
dc.identifier.urihttps://hdl.handle.net/10216/73041-
dc.language.isoeng
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCiências médicas e da saúde
dc.subjectMedical and Health sciences
dc.titleEvaluation of Sorafenib therapy in hepatocellular carcinoma
dc.typeDissertação
dc.contributor.uportoFaculdade de Medicina
dc.identifier.doi10.34626/ggt1-qe62
dc.identifier.tid201375230
dc.subject.fosCiências médicas e da saúde
dc.subject.fosMedical and Health sciences
thesis.degree.disciplineMestrado Integrado em Medicina
thesis.degree.grantorFaculdade de Medicina
thesis.degree.grantorUniversidade do Porto
thesis.degree.level1
Appears in Collections:FMUP - Dissertação

Files in This Item:
File Description SizeFormat 
29213.pdfEvaluation of Sorafenib therapy in hepatocellular carcinoma1.52 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons